Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ultra-proactive Therapeutic Drug Monitoring of Infliximab Based on Point-of-care-testing in Inflammatory Bowel Disease: a Pragmatic Trial

NCT04775732 is registered in ClinicalTrials.gov with Imelda GI Clinical Research Center as lead sponsor.

NCT NCT04775732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04775732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ultra-proactive Therapeutic Drug Monitoring of Infliximab Based on Point-of-care-testing in Inflammatory Bowel Disease: a Pragmatic Trial
Lead sponsor
Imelda GI Clinical Research Center
Phase
Phase 4
Overall status
Completed
Start date
June 1, 2018
Completion date
September 30, 2019
Enrollment
187 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, ulcerative colitis